{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:37:37Z","timestamp":1773149857973,"version":"3.50.1"},"reference-count":35,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Objective: Early diagnosis and treatment of metastatic pericardial disease are crucial to prevent the life-threatening complication of cardiac tamponade. Thin Layer Cytology (TLC), a widely adopted technique in cytology, has gained significant acceptance for most specimens. Our study aimed to assess the utility of TLC in diagnosing metastatic neoplasms and their origins in pericardial effusions, as well as monitoring response to chemotherapy. Methods: We examined 184 pericardial fluids collected by pericardiocentesis and processed using the ThinPrep liquid-based technique. Various immunocytochemical markers were used to determine the site of metastatic neoplasms. We also evaluated the response to therapy in 53 patients with lung and breast cancer. Results: Out of 184 specimens, 113 pericardial fluids were diagnosed as positive for malignancy, while 71 were negative. Twenty-three cases of unknown primary site were included in the total positive cases. Ninety cases positive for malignancy had a known primary site of origin, including 31 lung carcinomas, 22 breast carcinomas, 10 ovarian carcinomas, 6 T-cell lymphomas, 3 urinary bladder carcinomas, 4 renal carcinomas, 5 adenocarcinomas of the colon, 5 prostate carcinomas, 2 parotid adenocarcinomas, and 2 melanomas. Regarding the 53 cases with chemotherapy treatment, the cytologic examination of pericardial fluid showed a remarkable reduction in neoplastic burden after the third dose of cisplatin or thiotepa instilled into the pericardial cavity. ThinPrep provided excellent preservation of cytomorphological features, high cellularity per slide, and a clear background. This comprehensive analysis provides crucial information about the types and distribution of cancerous cells present in the samples. Conclusions: Thin Layer Cytology (TLC) is a valuable diagnostic tool for detecting metastatic pericardial malignancy. It allows the examination of exfoliated cells from the pericardial fluid, providing crucial information for diagnosis, management, and monitoring the acute responsiveness to intrapericardial chemotherapy. Immunocytochemistry (IHC) can identify specific markers for various types of cancer, enabling a more accurate diagnosis and guiding further treatment decisions.<\/jats:p>","DOI":"10.3390\/curroncol32060306","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T05:52:52Z","timestamp":1748325172000},"page":"306","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Value of Thin Layer Cytology in Cancer Patients\u2019 Pericardial Effusions"],"prefix":"10.3390","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0351-1319","authenticated-orcid":false,"given":"Christos","family":"Lafaras","sequence":"first","affiliation":[{"name":"Cardiology-Oncology Department, Theagenion Cancer Hospital, PC54623 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0223-185X","authenticated-orcid":false,"given":"Evdokia","family":"Mandala","sequence":"additional","affiliation":[{"name":"Division of Hematology, Forth Department of Medicine, School of Medicine Aristotle University of Thessaloniki, PC54623 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyranna","family":"Lafara","sequence":"additional","affiliation":[{"name":"Division of Hematology, Forth Department of Medicine, School of Medicine Aristotle University of Thessaloniki, PC54623 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Kalafatis","sequence":"additional","affiliation":[{"name":"Cardiology-Oncology Department, Theagenion Cancer Hospital, PC54623 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Achladas","sequence":"additional","affiliation":[{"name":"Division of Hematology, Forth Department of Medicine, School of Medicine Aristotle University of Thessaloniki, PC54623 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Koukoulitsa","sequence":"additional","affiliation":[{"name":"Cardiology-Oncology Department, Theagenion Cancer Hospital, PC54623 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrysoula","family":"Gouta","sequence":"additional","affiliation":[{"name":"Department of Cytopathology, Theagenion Cancer Hospital, PC54623 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodora","family":"Tsiouda","sequence":"additional","affiliation":[{"name":"Pulmonology-Oncology Department, Theagenion Cancer Hospital, PC54623 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soultana","family":"Skevoudi","sequence":"additional","affiliation":[{"name":"Department of Cytopathology, Theagenion Cancer Hospital, PC54623 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"ref_1","first-page":"8","article-title":"Pericardial effusion in oncological patients: Current knowledge and principles of management","volume":"10","author":"Mori","year":"2024","journal-title":"Cardiooncology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amjcard.2020.12.092","article-title":"Pericardial Involvement in Cancer","volume":"145","author":"Chahine","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1052-3359(25)00697-0","article-title":"Pericardial drainage procedures","volume":"5","author":"Moores","year":"1995","journal-title":"Chest Surg. Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1007\/s00330-004-2611-y","article-title":"Percutaneous treatment in patients presenting with malignant cardiac tamponade","volume":"15","author":"Marcy","year":"2005","journal-title":"Eur. Radiol."},{"key":"ref_5","first-page":"186","article-title":"Imaging of percutaneous pericardioperitoneal shunt in patient with malignant cardiac tamponade","volume":"87","author":"Marcy","year":"2004","journal-title":"JBR-BTR"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ccd.21431","article-title":"Primary percutanoeus ballon pericardiotomy for malignant pericardial effusion","volume":"71","author":"Swanson","year":"2008","journal-title":"Cathet. Cardiovasc. Interv."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.4103\/jfmpc.jfmpc_263_22","article-title":"A case series of malignant pericardial effusion","volume":"11","author":"Babu","year":"2022","journal-title":"J. Family Med. Prim. Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1200\/JCO.2005.00.745","article-title":"Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion","volume":"23","author":"Gornik","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.cjco.2024.05.003","article-title":"Malignant Pericardial Effusion: A Systematic Review","volume":"6","author":"Mudra","year":"2024","journal-title":"CJC Open"},{"key":"ref_10","first-page":"324","article-title":"Intrapericardial cisplatin administration after pericardiocentesis in patients with lung adenocarcinoma and malignant cardiac tamponade","volume":"46","author":"Bischiniotis","year":"2005","journal-title":"Hell. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00059-005-2709-2","article-title":"Women and pericardial neoplastic manifestations of the heart and pericardium","volume":"30","author":"Kisselbach","year":"2005","journal-title":"Herz"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0002-9149(00)00937-1","article-title":"Malignant cardiac tamponade with breast cancer treated by pericadiocentisis and intraperericardial administration of Triethylenethiophospharamide (Thiotepa)","volume":"86","author":"Bischiniotis","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1378\/chest.126.5.1412","article-title":"Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa","volume":"126","author":"Martinoni","year":"2004","journal-title":"Chest"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)","volume":"36","author":"Adler","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Rekhtman, N., Baine, M., and Bishop, J.A. (2019). Quick Reference Handbook for Surgical Pathologists, Springer.","DOI":"10.1007\/978-3-319-97508-5"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00059-019-4833-4","article-title":"Management of neoplastic pericardial disease. Behandlung neoplastisch bedingter Erkrankungen des Perikards","volume":"45","author":"Zhang","year":"2020","journal-title":"Herz"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/annonc\/mdh086","article-title":"Metastases to the heart","volume":"15","author":"Reyen","year":"2004","journal-title":"Ann. Oncol."},{"key":"ref_18","first-page":"177","article-title":"Metastatic heart disease","volume":"5","author":"Lafaras","year":"2006","journal-title":"Forum Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000325920","article-title":"Diagnostic efficacy of immunocytochemistry of Fine Needle Aspiration iopsies processed by Thin-Layer Cytology","volume":"50","author":"Fadda","year":"2006","journal-title":"Acta Cytol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ccc.2020.08.004","article-title":"Oncologic Emergencies: Traditional and Contemporary","volume":"37","author":"Spring","year":"2021","journal-title":"Crit. Care Clin."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1365-2303.2000.00260.x","article-title":"The usefulness of a panel of immunostains in the diagnosis and differentiated of metastatic malignancies in pericardial effusions","volume":"11","author":"Gupta","year":"2000","journal-title":"Cytopathology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/14779072.2020.1811087","article-title":"Update on diagnosis and management of neoplastic pericardial disease","volume":"18","author":"Avondo","year":"2020","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0090-4295(95)80025-5","article-title":"Malignant pericardial effusions as initial solitary site of metastasis from transitional cell carcinoma of the bladder","volume":"45","author":"Fabozzi","year":"1995","journal-title":"Urology"},{"key":"ref_24","first-page":"e33123","article-title":"Cardiac Tamponade in Patients with Breast Cancer: A Systematic Review","volume":"14","author":"Ilerhunmwuwa","year":"2022","journal-title":"Cureus"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7819-1-20","article-title":"Cardiac tamponade secondary to metastasis from adenocarcinoma of the parotid gland","volume":"1","author":"Barbetakis","year":"2003","journal-title":"World J. Surg. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.bjc.6605108","article-title":"Malignant pericardial effusion: Sclerotherapy or local chemotherapy?","volume":"101","author":"Lestuzzi","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1093\/eurheartj\/eht310.P4483","article-title":"Which is the best approach for neoplastic pericardial effusion? A retrospective analysis of 264 cases","volume":"34","author":"Lestuzzi","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.lungcan.2010.10.013","article-title":"Neoplastic pericardial disease in lung cancer: Impact on outcomes of different treatment strategies. A multicenter study","volume":"72","author":"Lestuzzi","year":"2011","journal-title":"Lung Cancer"},{"key":"ref_29","first-page":"131","article-title":"Response to neoplastic pericardial effusion","volume":"35","author":"Lestuzzi","year":"2012","journal-title":"Clin. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ccl.2017.07.005","article-title":"Pericardial Effusion","volume":"35","author":"Azarbal","year":"2017","journal-title":"Cardiol. Clin."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/JTO.0b013e31802c8260","article-title":"Catheter drainage followed by the instillation of bleomycin to manage malig nant pericardial effusion in non-small cell lung cancer: A multi-institutional phase II trial","volume":"2","author":"Maruyama","year":"2007","journal-title":"J. Thorac. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/sj.bjc.6604866","article-title":"A randomized trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer","volume":"100","author":"Kunitoh","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1200\/JCO.1996.14.12.3141","article-title":"Prospective comparison of the sclerosing agents doxycicline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade","volume":"14","author":"Liu","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jasc.2022.09.001","article-title":"A single tertiary institution review of the international system for serous fluid cytopathology and the impact of cell block and ancillary studies on its performance","volume":"12","author":"Lim","year":"2023","journal-title":"J. Am. Soc. Cytopathol."},{"key":"ref_35","first-page":"609","article-title":"Diagnostic accuracy of International System for Reporting Serous Fluid Cytopathology: A systematic review and meta-analysis in malignancy diagnosis","volume":"132","author":"Ahuja","year":"2024","journal-title":"Cancer Cytopathol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/6\/306\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:40:26Z","timestamp":1760031626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/6\/306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["curroncol32060306"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32060306","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]}}}